Dr. Daniela Irina Rosu, MD

Dr. Rosu practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.

Dr. Rosu's NPI, 1063948305, was assigned on May 5, 2017. Dr. Rosu holds Ohio license 35.147272.

Dr. Rosu's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.

Dr. Rosu's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dr. Rosu is also affiliated with Kettering Health Main Campus. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Rosu to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosu practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rosu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rosu is licensed in Ohio.

CMS data shows 1,155 Medicare services from Dr. Rosu across 24 procedure codes in 2024, for 584 Medicare patients. Medicare paid $47,765 for them.

CMS counts 584 Medicare patients who saw Dr. Rosu in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosu's median patient age at 65, with 56% women.

In 2024, Dr. Rosu wrote 1,298 Medicare Part D claims for 235 patients. 88% of them were for generic drugs. CMS names the drug for 1,164 of them, across 24 drugs with 11 or more claims each, at $96,492 in total drug cost. In 2023, CMS named 101 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Rosu for performance year 2024, reported as part of a group. Dr. Rosu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Rosu, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Patient Care Team, Workflow and Algorithms. Dr. Rosu's most frequent co-authors are Sameh Fikry Askandar, MD, Rami Nadim Khouzam, MD and Ildiko Agoston, MD.

CMS Open Payments shows 4 general payments to Dr. Rosu from 4 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $80.